23andMe Holding Co. (ME) NASDAQ
$0.60 0.01 (1.97%)
Market Cap: $184.53M
As of 05/16/24 03:57 PM EDT. Market closed.
23andMe Holding Co. (ME)
NASDAQ
$0.60
0.01 (1.97%)
Market Cap: $184.53M
As of 05/16/24 03:57 PM EDT. Market closed.
Add to Portfolio
23andme is the leading personal genetics company dedicated to helping individuals understand their own genetic information through dna analysis technologies and web-based interactive tools. the company's personal genome service® enables individuals to gain deeper insights into their ancestry and genetic make-up. the vision for 23andme is to personalize healthcare by making and supporting ... read more
COMPANY PROFILE
Sector
Industry
PRICE CHART FOR 23ANDME HOLDING CO
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.60
Previous Close
$0.59
Days Range
$0.58 - $0.64
52 week range
$0.35 - $2.20
Volume
2,716,354
Avg. Volume (30 days)
7,054,586
Market Cap
$184.53M
Dividend Yield
-
P/E
(0.35)
Shares Outstanding
315,436,358
Open
$0.60
Previous Close
$0.59
Days Range
$0.58 - $0.64
52 week range
$0.35 - $2.20
Volume
2,716,354
Avg. Volume (30 days)
7,054,586
Market Cap
$184.53M
Dividend Yield
-
P/E
(0.35)
Shares Outstanding
315,436,358
FINANCIAL STATEMENTS FOR 23ANDME HOLDING CO
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR 23ANDME HOLDING CO
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| HIBBS KATHY L | Chief Administrative Officer | May 02, 2024 | Option Exercise | $0.42 | 38,551 | 16,191 | 1,290,866 | May 06, 2024, 04:56 PM |
| HIBBS KATHY L | Chief Administrative Officer | May 02, 2024 | Sale | $0.49 | 38,551 | 19,048 | 1,252,315 | May 06, 2024, 04:56 PM |
| HIBBS KATHY L | Chief Administrative Officer | Apr 18, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,290,863 | Apr 19, 2024, 04:20 PM |
| HIBBS KATHY L | Chief Administrative Officer | Apr 18, 2024 | Sale | $0.47 | 38,548 | 18,148 | 1,252,315 | Apr 19, 2024, 04:20 PM |
| HIBBS KATHY L | Chief Administrative Officer | Apr 04, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,290,863 | Apr 05, 2024, 04:14 PM |
| HIBBS KATHY L | Chief Administrative Officer | Apr 04, 2024 | Sale | $0.50 | 38,548 | 19,282 | 1,252,315 | Apr 05, 2024, 04:14 PM |
| HIBBS KATHY L | Chief Administrative Officer | Mar 21, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,290,863 | Mar 22, 2024, 07:22 PM |
| HIBBS KATHY L | Chief Administrative Officer | Mar 21, 2024 | Sale | $0.46 | 38,548 | 17,894 | 1,252,315 | Mar 22, 2024, 07:22 PM |
| HIBBS KATHY L | Chief Administrative Officer | Mar 07, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,290,863 | Mar 11, 2024, 04:09 PM |
| HIBBS KATHY L | Chief Administrative Officer | Mar 07, 2024 | Sale | $0.53 | 38,548 | 20,430 | 1,252,315 | Mar 11, 2024, 04:09 PM |
| HIBBS KATHY L | Chief Administrative Officer | Feb 22, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,278,375 | Feb 23, 2024, 05:09 PM |
| HIBBS KATHY L | Chief Administrative Officer | Feb 22, 2024 | Sale | $0.61 | 38,548 | 23,325 | 1,239,827 | Feb 23, 2024, 05:09 PM |
| Richards William G | Head of Therapeutics Discovery | Feb 20, 2024 | Option Exercise | $0.72 | 18,497 | 13,244 | 646,540 | Feb 21, 2024, 04:36 PM |
| Selsavage Joseph Anthony | Interim CFO | Feb 20, 2024 | Option Exercise | $0.72 | 42,395 | 30,355 | 1,273,659 | Feb 21, 2024, 04:35 PM |
| HIBBS KATHY L | Chief Administrative Officer | Feb 20, 2024 | Option Exercise | $0.72 | 40,522 | 29,014 | 1,239,827 | Feb 21, 2024, 04:33 PM |
| HIBBS KATHY L | Chief Administrative Officer | Feb 15, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,318,897 | Feb 16, 2024, 04:47 PM |
| HIBBS KATHY L | Chief Administrative Officer | Feb 15, 2024 | Sale | $0.78 | 38,548 | 30,210 | 1,280,349 | Feb 16, 2024, 04:47 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jan 25, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,318,897 | Jan 26, 2024, 08:24 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jan 25, 2024 | Sale | $0.73 | 38,548 | 27,997 | 1,280,349 | Jan 26, 2024, 08:24 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jan 11, 2024 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,318,897 | Jan 12, 2024, 06:51 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jan 11, 2024 | Sale | $0.72 | 38,548 | 27,581 | 1,280,349 | Jan 12, 2024, 06:51 PM |
| HIBBS KATHY L | Chief Administrative Officer | Dec 28, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,318,897 | Dec 29, 2023, 04:04 PM |
| HIBBS KATHY L | Chief Administrative Officer | Dec 28, 2023 | Sale | $0.93 | 38,548 | 35,904 | 1,280,349 | Dec 29, 2023, 04:04 PM |
| HIBBS KATHY L | Chief Administrative Officer | Dec 14, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,318,897 | Dec 18, 2023, 04:17 PM |
| HIBBS KATHY L | Chief Administrative Officer | Dec 14, 2023 | Sale | $0.97 | 38,548 | 37,222 | 1,280,349 | Dec 18, 2023, 04:17 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 30, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,318,897 | Dec 01, 2023, 04:22 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 30, 2023 | Sale | $0.88 | 38,548 | 33,753 | 1,280,349 | Dec 01, 2023, 04:22 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 20, 2023 | Option Exercise | $0.91 | 4,627 | 4,211 | 1,280,349 | Nov 21, 2023, 04:45 PM |
| Richards William G | Head of Therapeutics Discovery | Nov 20, 2023 | Option Exercise | $0.91 | 5,695 | 5,182 | 665,037 | Nov 21, 2023, 04:41 PM |
| Selsavage Joseph Anthony | Interim CFO | Nov 20, 2023 | Option Exercise | $0.91 | 6,208 | 5,649 | 1,316,054 | Nov 21, 2023, 04:40 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 16, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,323,524 | Nov 17, 2023, 04:25 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 16, 2023 | Sale | $0.77 | 38,548 | 29,732 | 1,284,976 | Nov 17, 2023, 04:25 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 02, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,323,524 | Nov 03, 2023, 07:02 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 02, 2023 | Sale | $0.87 | 38,548 | 33,437 | 1,284,976 | Nov 03, 2023, 07:02 PM |
| HIBBS KATHY L | Chief Administrative Officer | Oct 19, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,323,524 | Oct 20, 2023, 05:28 PM |
| HIBBS KATHY L | Chief Administrative Officer | Oct 19, 2023 | Sale | $0.81 | 38,548 | 31,397 | 1,284,976 | Oct 20, 2023, 05:28 PM |
| HIBBS KATHY L | Chief Administrative Officer | Oct 05, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,323,524 | Oct 06, 2023, 05:16 PM |
| HIBBS KATHY L | Chief Administrative Officer | Oct 05, 2023 | Sale | $0.84 | 38,548 | 32,407 | 1,284,976 | Oct 06, 2023, 05:16 PM |
| HIBBS KATHY L | Chief Administrative Officer | Sep 21, 2023 | Option Exercise | $0.42 | 38,548 | 16,190 | 1,323,524 | Sep 25, 2023, 04:00 PM |
| HIBBS KATHY L | Chief Administrative Officer | Sep 21, 2023 | Sale | $1.00 | 38,548 | 38,583 | 1,284,976 | Sep 25, 2023, 04:00 PM |
| HIBBS KATHY L | Chief Administrative Officer | Sep 07, 2023 | Option Exercise | $0.42 | 40,894 | 17,175 | 299,880 | Sep 11, 2023, 04:04 PM |
| HIBBS KATHY L | Chief Administrative Officer | Sep 07, 2023 | Sale | $1.06 | 40,894 | 43,483 | 258,984 | Sep 11, 2023, 04:04 PM |
| Hernandez Sandra R MD | Director | Sep 06, 2023 | Option Exercise | $1.09 | 45,871 | 49,999 | 337,549 | Sep 08, 2023, 04:57 PM |
| MONTGOMERY RICE VALERIE MD | Director | Sep 06, 2023 | Option Exercise | $1.09 | 59,633 | 65,000 | 339,544 | Sep 08, 2023, 04:56 PM |
| Chung Patrick S | Director | Sep 06, 2023 | Option Exercise | $1.09 | 61,926 | 67,499 | 301,421 | Sep 08, 2023, 04:54 PM |
| BOTHA ROELOF | Director | Sep 06, 2023 | Option Exercise | $1.09 | 55,045 | 59,999 | 193,379 | Sep 08, 2023, 04:53 PM |
| Richards William G | Head of Therapeutics Discovery | Sep 05, 2023 | Sale | $1.08 | 2,538 | 2,741 | 211,041 | Sep 06, 2023, 05:01 PM |
| HIBBS KATHY L | Chief Administrative Officer | Aug 24, 2023 | Option Exercise | $0.42 | 40,894 | 17,175 | 293,406 | Aug 25, 2023, 04:57 PM |
| HIBBS KATHY L | Chief Administrative Officer | Aug 24, 2023 | Sale | $1.05 | 40,894 | 43,119 | 252,512 | Aug 25, 2023, 04:57 PM |
| HIBBS KATHY L | Chief Administrative Officer | Aug 20, 2023 | Option Exercise | $1.14 | 4,628 | 5,276 | 252,512 | Aug 22, 2023, 04:25 PM |
| Selsavage Joseph Anthony | Interim CFO | Aug 20, 2023 | Option Exercise | $1.14 | 6,209 | 7,078 | 286,537 | Aug 22, 2023, 04:24 PM |
| Richards William G | Head of Therapeutics Discovery | Aug 20, 2023 | Option Exercise | $1.14 | 8,185 | 9,331 | 211,041 | Aug 22, 2023, 04:22 PM |
| HIBBS KATHY L | Chief Administrative Officer | Aug 15, 2023 | Option Exercise | $0.42 | 40,894 | 17,175 | 298,034 | Aug 16, 2023, 04:51 PM |
| HIBBS KATHY L | Chief Administrative Officer | Aug 15, 2023 | Sale | $1.32 | 40,894 | 53,939 | 257,140 | Aug 16, 2023, 04:51 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jul 27, 2023 | Option Exercise | $0.42 | 40,894 | 17,175 | 298,034 | Jul 31, 2023, 04:23 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jul 27, 2023 | Sale | $1.89 | 40,894 | 77,257 | 257,140 | Jul 31, 2023, 04:23 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jul 13, 2023 | Option Exercise | $0.42 | 40,894 | 17,175 | 298,034 | Jul 14, 2023, 04:33 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jul 13, 2023 | Sale | $1.82 | 40,894 | 74,239 | 257,140 | Jul 14, 2023, 04:33 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jun 29, 2023 | Option Exercise | $0.42 | 40,894 | 17,175 | 298,034 | Jun 30, 2023, 04:22 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jun 29, 2023 | Sale | $1.72 | 40,894 | 70,432 | 257,140 | Jun 30, 2023, 04:22 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jun 05, 2023 | Option Exercise | $2.08 | 15,098 | 31,404 | 257,140 | Jun 07, 2023, 04:22 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Jun 05, 2023 | Option Exercise | $2.08 | 15,347 | 31,922 | 221,876 | Jun 07, 2023, 04:20 PM |
| Selsavage Joseph Anthony | Interim CFO | Jun 05, 2023 | Option Exercise | $2.08 | 13,075 | 27,196 | 292,746 | Jun 07, 2023, 04:18 PM |
| Selsavage Joseph Anthony | Interim CFO | May 20, 2023 | Option Exercise | $1.94 | 6,209 | 12,045 | 268,013 | May 23, 2023, 04:06 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | May 20, 2023 | Option Exercise | $1.94 | 4,628 | 8,978 | 192,842 | May 23, 2023, 04:05 PM |
| HIBBS KATHY L | Chief Administrative Officer | May 20, 2023 | Option Exercise | $1.94 | 4,628 | 8,978 | 228,579 | May 23, 2023, 04:04 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Feb 20, 2023 | Option Exercise | $2.87 | 5,457 | 15,662 | 191,705 | Feb 22, 2023, 05:12 PM |
| Selsavage Joseph Anthony | Interim CFO | Feb 20, 2023 | Option Exercise | $2.87 | 7,321 | 21,011 | 269,957 | Feb 22, 2023, 05:11 PM |
| HIBBS KATHY L | Chief Administrative Officer | Feb 20, 2023 | Option Exercise | $2.87 | 5,457 | 15,662 | 230,372 | Feb 22, 2023, 05:10 PM |
| HIBBS KATHY L | Chief Administrative Officer | Dec 05, 2022 | Sale | $3.25 | 26,259 | 85,342 | 235,829 | Dec 06, 2022, 05:44 PM |
| Selsavage Joseph Anthony | Interim CFO | Nov 20, 2022 | Option Exercise | $2.99 | 10,105 | 30,214 | 277,278 | Nov 22, 2022, 04:14 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 20, 2022 | Option Exercise | $2.99 | 4,628 | 13,838 | 262,088 | Nov 22, 2022, 04:12 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Nov 20, 2022 | Option Exercise | $2.99 | 4,628 | 13,838 | 197,162 | Nov 22, 2022, 04:11 PM |
| SCHELLER RICHARD H | Director | Nov 11, 2022 | Sale | $3.24 | 18,421 | 59,684 | 72,388 | Nov 14, 2022, 04:38 PM |
| BOTHA ROELOF | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,251 | 10,013 | 110,561 | Sep 08, 2022, 04:46 PM |
| Chung Patrick S | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,414 | 10,515 | 113,034 | Sep 08, 2022, 04:45 PM |
| Hernandez Sandra R MD | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,251 | 10,013 | 143,186 | Sep 08, 2022, 04:42 PM |
| MONTGOMERY RICE VALERIE MD | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,577 | 11,017 | 149,049 | Sep 08, 2022, 04:41 PM |
| Hernandez Sandra R MD | Director | Aug 25, 2022 | Option Exercise | $3.03 | 13,201 | 39,999 | 125,302 | Aug 29, 2022, 04:33 PM |
| MONTGOMERY RICE VALERIE MD | Director | Aug 25, 2022 | Option Exercise | $3.03 | 17,821 | 53,998 | 130,839 | Aug 29, 2022, 04:32 PM |
| Chung Patrick S | Director | Aug 25, 2022 | Option Exercise | $3.03 | 18,811 | 56,997 | 94,987 | Aug 29, 2022, 04:31 PM |
| BOTHA ROELOF | Director | Aug 25, 2022 | Option Exercise | $3.03 | 16,501 | 49,998 | 92,677 | Aug 29, 2022, 04:30 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Aug 24, 2022 | Sale | $3.64 | 8,753 | 31,861 | 196,083 | Aug 25, 2022, 05:00 PM |
| Schoch Steven J | Chief Financial Officer | Aug 20, 2022 | Option Exercise | $3.33 | 4,782 | 15,924 | 211,663 | Aug 22, 2022, 06:12 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Aug 20, 2022 | Option Exercise | $3.33 | 4,628 | 15,411 | 204,836 | Aug 22, 2022, 06:12 PM |
| HIBBS KATHY L | Chief Administrative Officer | Aug 20, 2022 | Option Exercise | $3.33 | 4,628 | 15,411 | 263,636 | Aug 22, 2022, 06:11 PM |
| Schoch Steven J | Chief Financial Officer | Jun 01, 2022 | Option Exercise | $2.82 | 4,782 | 13,485 | 216,445 | Jun 02, 2022, 04:28 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Jun 01, 2022 | Option Exercise | $2.82 | 4,627 | 13,048 | 209,464 | Jun 02, 2022, 04:26 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jun 01, 2022 | Option Exercise | $2.82 | 4,627 | 13,048 | 268,264 | Jun 02, 2022, 04:25 PM |
| Lovell Evan | Director | Mar 10, 2022 | Buy | $4.41 | 11,467 | 50,558 | 11,467 | Mar 11, 2022, 04:05 PM |
| HIBBS KATHY L | Chief Legal Officer | Jan 06, 2022 | Option Exercise | $0.42 | 58,800 | 24,696 | 58,800 | Jan 07, 2022, 04:11 PM |
| Lemon Steven | Vice President, Engineering | Jan 05, 2022 | Option Exercise | $0.23 | 127,647 | 29,359 | 127,647 | Jan 07, 2022, 04:08 PM |
| BROWN DOUGLAS R | Director | Oct 06, 2020 | Buy | $10.00 | 100,000 | 1,000,000 | 100,000 | Oct 08, 2020, 08:22 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| HIBBS KATHY L | Chief Administrative Officer | 05/02/2024 | 16,191 |
| HIBBS KATHY L | Chief Administrative Officer | 05/02/2024 | 19,048 |
| HIBBS KATHY L | Chief Administrative Officer | 04/18/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 04/18/2024 | 18,148 |
| HIBBS KATHY L | Chief Administrative Officer | 04/04/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 04/04/2024 | 19,282 |
| HIBBS KATHY L | Chief Administrative Officer | 03/21/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 03/21/2024 | 17,894 |
| HIBBS KATHY L | Chief Administrative Officer | 03/07/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 03/07/2024 | 20,430 |
| HIBBS KATHY L | Chief Administrative Officer | 02/22/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 02/22/2024 | 23,325 |
| Richards William G | Head of Therapeutics Discovery | 02/20/2024 | 13,244 |
| Selsavage Joseph Anthony | Interim CFO | 02/20/2024 | 30,355 |
| HIBBS KATHY L | Chief Administrative Officer | 02/20/2024 | 29,014 |
| HIBBS KATHY L | Chief Administrative Officer | 02/15/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 02/15/2024 | 30,210 |
| HIBBS KATHY L | Chief Administrative Officer | 01/25/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 01/25/2024 | 27,997 |
| HIBBS KATHY L | Chief Administrative Officer | 01/11/2024 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 01/11/2024 | 27,581 |
| HIBBS KATHY L | Chief Administrative Officer | 12/28/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 12/28/2023 | 35,904 |
| HIBBS KATHY L | Chief Administrative Officer | 12/14/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 12/14/2023 | 37,222 |
| HIBBS KATHY L | Chief Administrative Officer | 11/30/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 11/30/2023 | 33,753 |
| HIBBS KATHY L | Chief Administrative Officer | 11/20/2023 | 4,211 |
| Richards William G | Head of Therapeutics Discovery | 11/20/2023 | 5,182 |
| Selsavage Joseph Anthony | Interim CFO | 11/20/2023 | 5,649 |
| HIBBS KATHY L | Chief Administrative Officer | 11/16/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 11/16/2023 | 29,732 |
| HIBBS KATHY L | Chief Administrative Officer | 11/02/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 11/02/2023 | 33,437 |
| HIBBS KATHY L | Chief Administrative Officer | 10/19/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 10/19/2023 | 31,397 |
| HIBBS KATHY L | Chief Administrative Officer | 10/05/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 10/05/2023 | 32,407 |
| HIBBS KATHY L | Chief Administrative Officer | 09/21/2023 | 16,190 |
| HIBBS KATHY L | Chief Administrative Officer | 09/21/2023 | 38,583 |
| HIBBS KATHY L | Chief Administrative Officer | 09/07/2023 | 17,175 |
| HIBBS KATHY L | Chief Administrative Officer | 09/07/2023 | 43,483 |
| Hernandez Sandra R MD | Director | 09/06/2023 | 49,999 |
| MONTGOMERY RICE VALERIE MD | Director | 09/06/2023 | 65,000 |
| Chung Patrick S | Director | 09/06/2023 | 67,499 |
| BOTHA ROELOF | Director | 09/06/2023 | 59,999 |
| Richards William G | Head of Therapeutics Discovery | 09/05/2023 | 2,741 |
| HIBBS KATHY L | Chief Administrative Officer | 08/24/2023 | 17,175 |
| HIBBS KATHY L | Chief Administrative Officer | 08/24/2023 | 43,119 |
| HIBBS KATHY L | Chief Administrative Officer | 08/20/2023 | 5,276 |
| Selsavage Joseph Anthony | Interim CFO | 08/20/2023 | 7,078 |
| Richards William G | Head of Therapeutics Discovery | 08/20/2023 | 9,331 |
| HIBBS KATHY L | Chief Administrative Officer | 08/15/2023 | 17,175 |
| HIBBS KATHY L | Chief Administrative Officer | 08/15/2023 | 53,939 |
| HIBBS KATHY L | Chief Administrative Officer | 07/27/2023 | 17,175 |
| HIBBS KATHY L | Chief Administrative Officer | 07/27/2023 | 77,257 |
| HIBBS KATHY L | Chief Administrative Officer | 07/13/2023 | 17,175 |
| HIBBS KATHY L | Chief Administrative Officer | 07/13/2023 | 74,239 |
| HIBBS KATHY L | Chief Administrative Officer | 06/29/2023 | 17,175 |
| HIBBS KATHY L | Chief Administrative Officer | 06/29/2023 | 70,432 |
| HIBBS KATHY L | Chief Administrative Officer | 06/05/2023 | 31,404 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 06/05/2023 | 31,922 |
| Selsavage Joseph Anthony | Interim CFO | 06/05/2023 | 27,196 |
| Selsavage Joseph Anthony | Interim CFO | 05/20/2023 | 12,045 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 05/20/2023 | 8,978 |
| HIBBS KATHY L | Chief Administrative Officer | 05/20/2023 | 8,978 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 02/20/2023 | 15,662 |
| Selsavage Joseph Anthony | Interim CFO | 02/20/2023 | 21,011 |
| HIBBS KATHY L | Chief Administrative Officer | 02/20/2023 | 15,662 |
| HIBBS KATHY L | Chief Administrative Officer | 12/05/2022 | 85,342 |
| Selsavage Joseph Anthony | Interim CFO | 11/20/2022 | 30,214 |
| HIBBS KATHY L | Chief Administrative Officer | 11/20/2022 | 13,838 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 11/20/2022 | 13,838 |
| SCHELLER RICHARD H | Director | 11/11/2022 | 59,684 |
| BOTHA ROELOF | Director | 09/06/2022 | 10,013 |
| Chung Patrick S | Director | 09/06/2022 | 10,515 |
| Hernandez Sandra R MD | Director | 09/06/2022 | 10,013 |
| MONTGOMERY RICE VALERIE MD | Director | 09/06/2022 | 11,017 |
| Hernandez Sandra R MD | Director | 08/25/2022 | 39,999 |
| MONTGOMERY RICE VALERIE MD | Director | 08/25/2022 | 53,998 |
| Chung Patrick S | Director | 08/25/2022 | 56,997 |
| BOTHA ROELOF | Director | 08/25/2022 | 49,998 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 08/24/2022 | 31,861 |
| Schoch Steven J | Chief Financial Officer | 08/20/2022 | 15,924 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 08/20/2022 | 15,411 |
| HIBBS KATHY L | Chief Administrative Officer | 08/20/2022 | 15,411 |
| Schoch Steven J | Chief Financial Officer | 06/01/2022 | 13,485 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 06/01/2022 | 13,048 |
| HIBBS KATHY L | Chief Administrative Officer | 06/01/2022 | 13,048 |
| Lovell Evan | Director | 03/10/2022 | 50,558 |
| HIBBS KATHY L | Chief Legal Officer | 01/06/2022 | 24,696 |
| Lemon Steven | Vice President, Engineering | 01/05/2022 | 29,359 |
| BROWN DOUGLAS R | Director | 10/06/2020 | 1,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN 23ANDME HOLDING CO
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 21,559,196 | 0.00027% | -4.04% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 7,483,379 | 0.00037% | 6.02% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 4,848,161 | 0.00405% | 39.39% | Other |
| DRAGONEER INVESTMENT GROUP, LLC | 500,000 | 0.00616% | No change | Growth |
| AQR CAPITAL MANAGEMENT LLC | 180,754 | 0.00016% | 1076.25% | Other |
CHANGE IN SHARES OUTSTANDING FOR 23ANDME HOLDING CO
STOCK BUYBACKS FOR 23ANDME HOLDING CO
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.25%
1Q
06/30/2023
4.01%
2Q
03/31/2023
5.40%
3Q
12/31/2022
6.04%
4Q
09/30/2022
6.87%
5Q
06/30/2022
7.68%
6Q
03/31/2022
32.99%
7Q
12/31/2021
12.71%
8Q
09/30/2021
18.17%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR 23ANDME HOLDING CO
LOADING...